| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Charles River Laboratories International Inc (NYSE: CRL)
CRL Technical Analysis
5
| As on 9th Jun 2023 CRL STOCK Price closed @ 197.68 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 254.32 & Strong Sell for SHORT-TERM with Stoploss of 327.29 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CRLSTOCK Price
| Open | 203.48 | Change | Price | % |
| High | 204.99 | 1 Day | -5.49 | -2.70 |
| Low | 197.55 | 1 Week | 4.30 | 2.22 |
| Close | 197.68 | 1 Month | 13.97 | 7.60 |
| Volume | 294400 | 1 Year | -163.35 | -45.25 |
| 52 Week High 376.78 | 52 Week Low 183.71 | ||||
NYSE USA Most Active Stocks
| DDR | 15.44 | -4.46% |
| NIO | 7.73 | -0.77% |
| TWTR | 53.70 | 0.66% |
| CVNA | 19.07 | -21.30% |
| BACA-U | 302.00 | 0.67% |
| PLTR | 15.02 | -1.12% |
| F | 13.74 | 1.18% |
| CS | 0.89 | 1.14% |
| RPAI | 13.15 | -3.17% |
| AUY | 5.85 | -0.68% |
NYSE USA Top Gainers Stocks
NYSE USA Top Losers Stocks
| CRL Daily Charts |
CRL Intraday Charts |
Whats New @ Bazaartrend |
CRL Free Analysis |
|
|
CRL Important Levels Intraday
| RESISTANCE | 212.02 |
| RESISTANCE | 207.42 |
| RESISTANCE | 204.58 |
| RESISTANCE | 201.73 |
| SUPPORT | 193.63 |
| SUPPORT | 190.78 |
| SUPPORT | 187.94 |
| SUPPORT | 183.34 |
CRL Forecast May 2024
| 4th UP Forecast | 349.99 |
| 3rd UP Forecast | 301.14 |
| 2nd UP Forecast | 270.95 |
| 1st UP Forecast | 240.76 |
| 1st DOWN Forecast | 154.6 |
| 2nd DOWN Forecast | 124.41 |
| 3rd DOWN Forecast | 94.22 |
| 4th DOWN Forecast | 45.37 |
CRL Weekly Forecast
| 4th UP Forecast | 272.18 |
| 3rd UP Forecast | 248.29 |
| 2nd UP Forecast | 233.52 |
| 1st UP Forecast | 218.75 |
| 1st DOWN Forecast | 176.61 |
| 2nd DOWN Forecast | 161.84 |
| 3rd DOWN Forecast | 147.07 |
| 4th DOWN Forecast | 123.18 |
CRL Forecast2024
| 4th UP Forecast | 580.05 |
| 3rd UP Forecast | 457.42 |
| 2nd UP Forecast | 381.62 |
| 1st UP Forecast | 305.82 |
| 1st DOWN Forecast | 89.54 |
| 2nd DOWN Forecast | 13.74 |
| 3rd DOWN Forecast | -62.06 |
| 4th DOWN Forecast | -184.69 |
Charles River Laboratories International Inc ( NYSE USA Symbol : CRL )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
CRL Business Profile
Charles River Laboratories International, Inc., an early-stage contract research company, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment produces and sells research model strains and purpose-bred rats and mice for use by researchers. It also provides a range of services to assist its clients in supporting the use of research models in research and screening non-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets and chemical compounds through delivery of non-clinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. It also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies; and avian vaccine services that provide specific-pathogen-free (SPF) fertile chicken eggs, SPF chickens, and diagnostic products used to manufacture vaccines. The company was founded in 1947 and is based in Wilmington, Massachusetts. Address: 251 Ballardvale Street, Wilmington, MA, United States, 01887
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service